StockData

Stryker vs Zimmer Biomet

SYK and ZBH side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How SYK and ZBH compare

Stryker is the larger company, worth 6.2 times as much as Zimmer Biomet ($121B against $19.5B).

On earnings, Zimmer Biomet is cheaper: it trades at 24.8× trailing earnings, against 33.8× for Stryker.

Zimmer Biomet grew revenue faster over the last twelve months (8.6% versus 7.9% for Stryker).

Stryker keeps more of each dollar of sales as profit, with a net margin of 13.8% compared with 9.5% at Zimmer Biomet.

Both pay dividends: Stryker yields 1.1% and Zimmer Biomet 0.94%.

Stryker scores higher on the StockData Score (18 against 16 for Zimmer Biomet), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricSYKZBH
Size and price
Market cap$121B$19.5B
Share price$317.54$102.09
Change, 1 year−12.3%13.5%
Change, 5 years30.4%−18.7%
Beta (5Y)−0.03−0.09
Employees56K17K
StockData Score
Total score18 (better)16
Valuation score35 (better)
Growth score5 (better)1
Performance score33
Health score4 (better)3
Dividend score34 (better)
Valuation
P/E33.8×24.8× (better)
P/S4.6×2.3× (better)
P/B–1.5×
EV/EBITDA18.8×11.5× (better)
P/FCF26.4×12.8× (better)
PEG3.120.52 (better)
FCF yield3.8%7.8% (better)
Fair value$338.51$124.85
Margin of safety6.2%18.2% (better)
Growth
Revenue growth (TTM)7.9%8.6% (better)
Revenue growth, 5Y average11.8% (better)6.1%
Net income growth (TTM)23.1% (better)−2.0%
EPS growth (TTM)23.4% (better)0.00%
EPS growth, 5Y average14.9%–
Profitability
Gross margin65.3%69.9% (better)
Operating margin20.7% (better)14.2%
Net margin13.8% (better)9.5%
FCF margin17.4%17.9% (better)
Return on equity–6.4%
Return on invested capital–5.3%
Financial health
Debt / equity–0.59
Net debt / EBITDA1.65 (better)3.06
Interest coverage9.3×–
Current ratio2.18 (better)1.69
Altman Z-score4.81 (better)2.54
Piotroski F-score56 (better)
Dividends and buybacks
Dividend yield1.1% (better)0.94%
Payout ratio36.8%23.4%
Years of dividend growth–0
Dividend growth, 5Y average–0.00%
Buyback yield–3.9%
Shareholder yield1.1%4.8% (better)
Ownership
Held by institutions80.9%104%
Held by insiders4.2%0.19%
Insider net buying, 12 months−$580M−$1.6M (better)
Superinvestors holding11
Short interest, % of float1.8%4.1%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.